HCohen schreef op 22 december 2021 12:13:
Onderstaand uit de Guardian(Hugo lees je mee, actie!)
04:48UK signs contracts for 4.25m courses of antivirals
The Department of Health and Social Care has this morning announced that it has signed contracts to buy another 4.25m courses of antivirals to protect patients from Covid. In a news release it says:
The two new contracts are for 1.75m additional courses of Merck Sharp and Dohme’s (MSD) molnupiravir (Lagevrio®) and 2.5m additional courses of PF-07321332/ritonavir (Paxlovid™) from Pfizer, which will be available from early next year and are both expected to be effective against Omicron.
The 4.25m courses are in addition to the procurement of 480,000 courses of molnupiravir and 250,000 courses of PF-07321332/ritonavir announced in October this year ...
Molnupiravir has shown in clinical trials to reduce the risk of hospitalisation or death for at-risk, non-hospitalised adults with mild to moderate Covid-19 by 30%. PF-07321332/ritonavir reduced the relative risk of Covid-19-associated hospitalisation or death by 89% in those who received treatment within three days of symptoms appearing.
DHSC is also encourage people over 50, or with an underlying health condition, who test positive for Covid to take part in a study to test the impact of these drugs. You can sign up here.